Malady Kyle sold $49K of VZ
Malady Kyle (EVP and Group CEO-VZ Business) sold 1,100 shares of VERIZON COMMUNICATIONS INC (VZ) at $44.79 on 2026-11-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The disclosed sale is small relative to Verizon's market cap and unlikely to move the stock.
Market read
A routine insider sale with limited material impact; traders need not adjust positions.
What to watch
Potential upcoming earnings or strategic moves not disclosed in the filing.
Background
Form 4 filings disclose insider transactions; Kyle Malady is Verizon's EVP and Group CEO of the Business segment.
Ticker impact
Officer Kyle Malady sold 1,100 Verizon shares for $49,269 via a 10b5‑1 plan, reducing his holding to 97,766 shares.
likely slight pressure as the market prices in the insider sell
The transaction size is modest ($49k) and represents a tiny fraction of total float, so any price effect should be minimal.
Market effects
None significant for the telecom sector.
No regional impact.
Minimal.
Counterpoint
The sale could be interpreted as a routine portfolio rebalancing rather than a lack of confidence.
Key entities
- CompanyVerizon Communications Inc.
US‑listed telecom provider (ticker VZ).
- ExecutiveKyle Malady
EVP and Group CEO‑VZ Business, insider seller.

